TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TVGN

Tevogen Bio Holdings Inc.

Healthcare · Biotechnology

7.70$ -1.2% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Tevogen Bio Holdings Inc. (TVGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 29.8% of the shares are freely tradable; institutional investors hold 3.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 3.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 74.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 29.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 1.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 7Mio.

Largest Shareholders

Institutions

Institutions TVGN
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 0.52 33,248 +0.0 03/31/2026
BlackRock Inc 0.38 24,395 -98.0 03/31/2026
Morgan Stanley - Brokerage Accounts 0.27 17,334 -93.1 03/31/2026
Geode Capital Management, LLC 0.25 15,734 -97.2 03/31/2026
Deutsche Bank AG 0.24 15,324 -91.2 03/31/2026
FMR Inc 0.16 10,157 -90.0 03/31/2026
Vanguard Portfolio Management, LLC 0.07 4,525 +0.0 03/31/2026
UBS Group AG 0.06 3,567 -93.5 03/31/2026

Funds

Funds TVGN
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 0.24 15,102 +0.0 07/31/2026
Goldman Sachs Absolute Ret Trckr Instl 0.22 13,951 +432.5 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings TVGN
Person Role Shares Value As of Type
Saadi Ryan H. Chief Executive Officer 11,705,689 90,133,805 $ Sep 14, 2026 direct
Desai Kirti Chief Financial Officer 992,983 7,645,969 $ Sep 14, 2026 direct
Patton Curtis L. Director 139,192 1,071,778 $ Sep 11, 2026 direct
Feike Jeffrey L. Director 131,435 1,012,050 $ Sep 11, 2026 direct
Sordillo Victor J. Director 126,539 974,350 $ Sep 11, 2026 direct
Goh Keow Lin Director 123,678 952,321 $ Sep 11, 2026 direct
Podlogar Susan M Director 123,678 952,321 $ Sep 11, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 14, 2026 Saadi Ryan H. Chief Executive Officer Other 8,000,000 0.00
Sep 14, 2026 Desai Kirti Chief Financial Officer Other 750,000 0.00
Sep 11, 2026 Goh Keow Lin Director Other 75,000 0.00
Sep 11, 2026 Podlogar Susan M Director Other 75,000 0.00
Sep 11, 2026 Sordillo Victor J. Director Other 75,000 0.00
Sep 11, 2026 Feike Jeffrey L. Director Other 75,000 0.00
Sep 11, 2026 Patton Curtis L. Director Other 75,000 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?